Recovery article

Semax + Selank Stack Protocol Guide — Path To Peptides

Protocol Overview Synergy & Mechanism Semax Mechanism Semax is a heptapeptide analog of ACTH(4-10) that dramatically upregulates BDNF and NGF expression in the brain. It enhances dopaminergic and serotonergic neurotransmission, improves attention, working memo

By Recovery & Performance Peptides Editorial Team Published September 3, 2026

Protocol Overview

Synergy & Mechanism

Semax Mechanism

Semax is a heptapeptide analog of ACTH(4-10) that dramatically upregulates BDNF and NGF expression in the brain. It enhances dopaminergic and serotonergic neurotransmission, improves attention, working memory, and verbal fluency. Unlike stimulants, it promotes genuine neuroplasticity rather than just temporary arousal. Effects are both acute (within hours) and cumulative (building over weeks).

Selank Synergy

Selank is a tuftsin analog that provides potent anxiolytic effects by stabilizing enkephalins (natural opioid peptides) and modulating GABA-A receptor sensitivity. Unlike benzodiazepines, it produces no sedation, cognitive impairment, or dependence. By removing anxiety and mental noise, Selank allows the cognitive enhancement from Semax to manifest fully, creating the ideal focused-yet-calm mental state.

Combined Dosing Protocol

Standard

Semax 0.1% 2 drops/nostril 2x/day

Selank 0.15% 2 drops/nostril 2x/day

AM + midday

4-8 weeks

Enhanced

Semax N-Acetyl 0.1% 2 drops 3x/day

Selank N-Acetyl 0.15% 2 drops 3x/day

AM/midday/PM

8-12 weeks

SubQ

Semax 200mcg SubQ AM

Selank 250mcg SubQ AM

AM together

6-8 weeks

Reconstitution & Preparation

Intranasal Preparation

Semax 0.1% nasal spray: ready to use

Selank 0.15% nasal spray: ready to use

N-Acetyl versions have enhanced bioavailability

Store refrigerated, use within 30 days

SubQ Preparation (Alternative)

Semax vial: reconstitute per label

Selank vial: reconstitute per label

200-250mcg doses subcutaneously

Intranasal preferred for cognitive effects

Stacking Schedule (AM/PM Timing)

AM Protocol

Morning: Semax 0.1% 2 drops per nostril

Morning: Selank 0.15% 2 drops per nostril

Wait 5 min between compounds for absorption

Effects onset within 15-30 minutes

Midday/PM Protocol

Midday (12-2 PM): Repeat both compounds

Optional PM: Selank only for evening anxiety

Avoid Semax after 4 PM if sensitive to stimulation

Effects are cumulative over days/weeks

Expected Timeline

Side Effects & Monitoring

Common Side Effects

Mild nasal irritation (intranasal, transient)

Headache (uncommon, first few days)

Mild stimulation from Semax (reduce dose)

Drowsiness from Selank (uncommon)

Both compounds are extremely well-tolerated with decades of clinical use in Russia.

Precautions

Semax may overstimulate in mania-prone individuals

Selank generally very safe

N-Acetyl versions more potent - start with standard

No known drug interactions

Blood Work Recommendations

Neuro Panel

BDNF (serum), cortisol (AM)

Baseline, Week 4

Basic

CBC, CMP

Baseline, Week 8

Thyroid

TSH

BDNF levels may increase 30-50% with Semax. AM cortisol tracks HPA axis function. Routine blood work is sufficient for most.

Related Protocols & Tools

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

COACH'S BOARD / KEY POINTS

Semax and Selank create synergy through complementary neurotransmitter systems—cholinergic/dopaminergic activation (Semax) combined with GABAergic anxiolysis (Selank)—not through overlapping mechanisms.
The correct dosing sequence is Semax first (300–600 mcg intranasal), followed by Selank (250–500 mcg) 30–45 minutes later—simultaneous administration creates muddy, inconsistent effects.
Semax reaches peak acetylcholine activity within 20–30 minutes of intranasal administration, while Selank's GABAergic modulation builds over 45–60 minutes—spacing them allows Semax to anchor before Selank amplifies.
The synergistic window lasts 3–4 hours and produces alert calm—high mental clarity without anxiety, reduced cortisol reactivity without sedation.
Reversing the order (Selank first, then Semax) or dosing both simultaneously eliminates the phased interaction that creates the stack's unique cognitive profile.
Both peptides are administered intranasally using precision nasal spray dispensers—this route bypasses hepatic metabolism and delivers peptides to the CNS via olfactory pathways within minutes.

SOURCE / realpeptides.co ↗

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Sourcing a Research-Grade Semax Selank Blend

For researchers studying combination intranasal peptide pharmacology, compound quality directly affects research validity — and combination formulations amplify this concern because each component must meet purity standards. Research-grade blend formulations should be verified for purity through HPLC analysis with mass spectrometry identity confirmation, with batch-specific Certificates of Analysis documenting both component peptides. PSPeptides supplies research-grade peptides at 99%+ verified purity with batch-specific third-party HPLC testing and US-based manufacturing. Researchers can explore the Semax Selank blend and individual nootropic peptides at PSPeptides. The research peptide supplier selection guide covers the broader vendor evaluation framework, and the peptide purity and COA interpretation guide covers what to verify in documentation. The Semax Selank blend benefits from sourcing where both component compounds are independently verified. Because a blend combines two peptides, any quality issue in either component compromises the combination research data. The verified-purity sourcing standard is therefore particularly important for blend research. Beyond purity verification, sourcing a research-grade Semax Selank blend benefits from operational reliability — and the combination format makes this especially important, since both component peptides must meet quality standards independently. PSPeptides maintains 99%+ HPLC-verified purity with batch-specific Certificates of Analysis and US-based manufacturing, with free UPS 2nd Day Air shipping on research orders over $200. For combination research, where attributing effects to the pairing requires confidence in both compounds, this verified-purity standard across both components is a practical research necessity rather than a luxury. The consolidation of the research peptide market after several major vendor closures has made supplier reliability central to research planning. For ongoing combination research, establishing a relationship with a quality-first supplier that documents both component peptides transparently protects against the supply disruptions that can compromise a research timeline. Researchers can browse the full catalog, review the supporting documentation for each compound, and select the combination formulation or individual components appropriate to their research questions.